Chemed (CHE) EBIT (2009 - 2026)

Chemed has reported EBIT for 18 years, with the latest figure at $84.6 million in Q1 2026.

• For the quarter ending Q1 2026, EBIT fell 10.74% year-over-year to $84.6 million; the trailing twelve-month figure through Mar 2026 stood at $328.1 million (down 15.65% YoY), and the FY2025 full-year result was $338.2 million, down 7.71% from the prior year.
• EBIT for Q1 2026 stood at $84.6 million, down from $100.7 million in the prior quarter.
• The five-year high for EBIT was $113.9 million in Q4 2024, with the low at -$192.9 million in Q4 2022.
• Average EBIT over 5 years is $70.5 million, with a median of $86.8 million recorded in 2023.
• Peak annual rise in EBIT reached 157.74% in 2023, while the deepest fall reached 24.4% in 2023.
• Tracing CHE's EBIT over 5 years: stood at -$192.9 million in 2022, then surged by 157.74% to $111.4 million in 2023, then advanced by 2.23% to $113.9 million in 2024, then declined by 11.61% to $100.7 million in 2025, then dropped by 15.97% to $84.6 million in 2026.
• The last three EBIT figures came in at $84.6 million (Q1 2026), $100.7 million (Q4 2025), and $74.8 million (Q3 2025), per Business Quant data.

Peer Comparison